Ask AI
ProCE Banner Activity

Aligning Current EBC Treatment With Current NCCN Guidelines and Expert Recommendations

Slideset

Download these slides from a leading expert with the latest information and insights on adjuvant therapy using CDK4/6 inhibitors for patients with HR+/HER2- EBC. 

Released: May 30, 2025

Expiration: November 29, 2025

Share

Provided by

Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation